Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. KMDA
KMDA logo

KMDA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Kamada Ltd (KMDA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
7.310
1 Day change
-2.40%
52 Week Range
9.350
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Kamada Ltd (KMDA) is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock is technically stable to slightly bullish, but the setup is not compelling enough to call it a clear buy at current levels. With no AI Stock Picker or SwingMax signal, no recent news catalyst, neutral hedge fund and insider activity, and no financial snapshot available to confirm growth momentum, the best call is to hold and wait for a better confirmation of trend or fundamentals before committing capital.

Technical Analysis

KMDA is trading at 7.49, essentially flat versus the prior close of 7.50. The MACD histogram is positive and expanding, which supports short-term bullish momentum. RSI_6 at 69.0 is near overbought territory, suggesting the stock is somewhat extended rather than deeply attractive for fresh entry. Moving averages are converging, which points to a developing trend but not a strong breakout yet. Key levels matter here: pivot 7.328 is below price, while resistance sits at 7.606 and 7.779. That means upside from here is possible, but the stock is already close to first resistance, so the immediate risk/reward is not especially attractive for a beginner long-term buy.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is strongly bullish based on the very low open interest put-call ratio of 0.05 and zero put volume, but the actual options activity is thin, with zero call and put volume today. Implied volatility is extremely elevated at 344.44 with IV percentile 99.6 and IV rank 99.7, which suggests option pricing is very expensive and often reflects event uncertainty or a speculative setup. Because there is no real volume confirmation, the options data leans bullish in positioning but not in active conviction.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
12
Buy
1

Positive Catalysts

  • ["MACD histogram is positive and expanding, indicating improving momentum.", "Options positioning is heavily skewed toward calls, with a very low put-call ratio.", "Stock pattern analysis suggests a 70% chance of a 2.64% move higher next day.", "No recent negative news in the past week."]

Neutral/Negative Catalysts

  • ["No AI Stock Picker signal today.", "No SwingMax signal recently.", "No recent news catalyst to drive a fresh move.", "Insiders are neutral over the past month.", "Hedge funds are neutral over the last quarter.", "RSI is near overbought, so upside may be limited near-term.", "Options implied volatility is extremely high, making the setup less attractive for conservative long-term entry.", "No recent congress trading data available."]

Financial Performance

No usable latest-quarter financial snapshot was provided because the data returned an error, so there is no verified quarterly revenue, earnings, or margin trend to assess. The latest quarter season cannot be identified from the supplied data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no visible trend in Wall Street revisions. Based on the available information, the Wall Street view appears mixed rather than strongly bullish: there is some supportive technical and options sentiment, but no confirmed analyst upgrade cycle or fresh catalyst to justify a strong buy call. Pros include improving momentum and bullish options positioning; cons include lack of supporting analyst action and absence of fundamental confirmation.

Wall Street analysts forecast KMDA stock price to rise
2 Analyst Rating
Wall Street analysts forecast KMDA stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 7.490
sliders
Low
13
Averages
14
High
15
Current: 7.490
sliders
Low
13
Averages
14
High
15
H.C. Wainwright
Buy
maintain
$11 -> $13
AI Analysis
2025-12-09
Reason
H.C. Wainwright
Price Target
$11 -> $13
AI Analysis
2025-12-09
maintain
Buy
Reason
H.C. Wainwright raised the firm's price target on Kamada to $13 from $11 and keeps a Buy rating on the shares. The company decided to discontinue its Phase 3 inhaled alpha-1 antitrypsin deficiency clinical trial based on the results of the planned interim futility analysis, the analyst tells investors in a research note. The firm says the decision helps to refocus the company on its core products and eliminates a "long over-hanging distraction that was unlikely to be fruitful."

People Also Watch